According to Yaegar et al. (2016) [33], colitis-associated tumors often contain mutations and copy number variation in genes involved in RTK/KRAS signaling (57%), Wnt signaling, TGFβ and MYC (41%), cell cycle regulation (24%) and p53 signaling (83%). This evidence concerns the gene TP53 and colitis.